The role of a drug-loaded poly (lactic co-glycolic acid) (PLGA) copolymer stent in the treatment of ovarian cancer
Objectives: Cisplatin (CDDP) is a widely used and effective basic chemotherapeutic drug for the treatment of a variety of tumors, including ovarian cancer. However, adverse side effects and acquired drug resistance are observed in the clinical application of CDDP. Identifying a mode of administratio...
Main Authors: | Yanqing Wang, Xiaoyin Qiao, Xiao Yang, Mengqin Yuan, Shu Xian, Li Zhang, Dongyong Yang, Shiyi Liu, Fangfang Dai, Zhikai Tan, Yanxiang Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2020-02-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | http://www.cancerbiomed.org/index.php/cocr/article/view/1553 |
Similar Items
-
BNIP3 contributes to cisplatin‐induced apoptosis in ovarian cancer cells
by: Jinghui Jia, et al.
Published: (2020-08-01) -
The first experience with intraabdominal chemotherapy in patients with disseminated ovarian cancer
by: A. S. Tyulyandina, et al.
Published: (2014-08-01) -
Synergism of antitumor action of dioxadet and cisplatin in model of ascitic ovarian tumor
by: V. G. Bespalov, et al.
Published: (2016-02-01) -
Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells
by: Li Liu, et al.
Published: (2019-07-01) -
Coincidental Occurrence of Acute In-stent Thrombosis and Iatrogenic Vessel Perforation During a Wingspan Stent Placement: Management with a Stent In-stent Technique
by: Sun Joo Lee, et al.
Published: (2012-02-01)